Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Controlled Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Controlled Study
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF NEPHROLOGY
Volume -, Issue -, Pages 1-10
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000534484
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial
- (2022) Chien-Te Lee et al. PLoS One
- Ferric citrate for the treatment of hyperphosphatemia and anemia in patients with chronic kidney disease: a meta-analysis of randomized clinical trials
- (2022) Li Li et al. RENAL FAILURE
- Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials
- (2021) Yan Zhu et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia
- (2021) Michel Vallée et al. International Journal of Nephrology and Renovascular Disease
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
- (2021) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment
- (2020) Elizabeth Katherine Batchelor et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective
- (2020) Julia J. Scialla et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD
- (2020) Rebecca Womack et al. Clinical Journal of the American Society of Nephrology
- Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis: Ten-year outcomes of the Q-Cohort Study
- (2020) Hiroto Hiyamuta et al. ATHEROSCLEROSIS
- Dietary Therapy for Managing Hyperphosphatemia
- (2020) Yoko Narasaki et al. Clinical Journal of the American Society of Nephrology
- China Kidney Disease Network (CK-NET) 2015 Annual Data Report
- (2019) Luxia Zhang et al. Kidney International Supplements
- Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
- (2019) Tomas Ganz et al. DRUGS
- The Key Role of Phosphate on Vascular Calcification
- (2019) Mario Cozzolino et al. Toxins
- A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD
- (2019) Geoffrey A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study
- (2017) Fumihiko Koiwa et al. JOURNAL OF RENAL NUTRITION
- Phosphate binders in chronic kidney disease: a systematic review of recent data
- (2016) Jürgen Floege JOURNAL OF NEPHROLOGY
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
- (2015) K. Umanath et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
- (2014) K. Yokoyama et al. Clinical Journal of the American Society of Nephrology
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study
- (2014) Chien-Te Lee et al. JOURNAL OF NEPHROLOGY
- Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
- (2014) J. B. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data
- (2014) Marvin Sinsakul et al. Expert Review of Clinical Pharmacology
- Dose-Response and Efficacy of Ferric Citrate to Treat Hyperphosphatemia in Hemodialysis Patients: A Short-term Randomized Trial
- (2013) Jamie P. Dwyer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study
- (2013) N. Chen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic review
- (2013) Chenglong Zhang et al. BMC Nephrology
- Effect of Oral JTT-751 (Ferric Citrate) on Hyperphosphatemia in Hemodialysis Patients: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
- (2012) Keitaro Yokoyama et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study
- (2012) Soichiro Iimori et al. Clinical and Experimental Nephrology
- Effect of Sevelamer and Calcium-Based Phosphate Binders on Coronary Artery Calcification and Accumulation of Circulating Advanced Glycation End Products in Hemodialysis Patients
- (2011) Takatoshi Kakuta et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease
- (2011) C. M. O'Seaghdha et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
- (2010) V. M. Brandenburg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Prediction, Progression, and Outcomes of Chronic Kidney Disease in Older Adults
- (2009) S. Anderson et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now